Estados Unidos · Plataformas y datos · MarketBeat
Zymeworks (NASDAQ:ZYME) to Buy Back $200 million in Stock

Resumen detallado
Zymeworks (NASDAQ:ZYME - Get Free Report) declared that its Board of Directors has approved a stock buyback plan on Monday, November 16th, RTT News reports. The company plans to buy back $200 million in outstanding shares. This repurchase authorization allows the company to buy up to 10.9% of its stock through open market purchases.
MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.marketbeat.com)




